Loopbaan van Frank L. Porfido
Eerdere bekende functies van Frank L. Porfido
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Financieel Directeur/CFO | 13-05-2021 | 16-09-2022 |
| UroGen Pharma, Inc. | Corporate Officer/Principal | 01-06-2019 | 01-05-2021 |
Opleiding van Frank L. Porfido
| Pace University | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
| UroGen Pharma, Inc. | Health Technology |
- Beurs
- Insiders
- Frank L. Porfido
- Ervaring